痛みに対するマインドフルネス瞑想はプラセボではないことが脳スキャンで明らかになる(Mindfulness Meditation for Pain Is Not a Placebo)

ad

2024-09-05 カリフォルニア大学サンディエゴ校(UCSD)

痛みに対するマインドフルネス瞑想はプラセボではないことが脳スキャンで明らかになる(Mindfulness Meditation for Pain Is Not a Placebo)These brain scans show different neural signatures associated with pain response: the NAPS (left) is associated with the emotional experience of pain, the SIIPS-1 (center) is related to our expectations of pain and other psychosocial factors, and the NPS (right) is associated with pain intensity. Researchers at UC San Diego found that mindfulness meditation can modulate the NAPS and NPS, but not the SIIPS-1, showing that different parts of the brain are engaged in mindfulness-based pain relief compared to placebo. Photo credit: UC San Diego Health Sciences

カリフォルニア大学サンディエゴ校の研究で、マインドフルネス瞑想が痛みを軽減する効果がプラセボ効果とは異なる脳のメカニズムによることが明らかになりました。115人の健康な参加者を対象に、マインドフルネス瞑想、偽瞑想、プラセボクリーム、およびコントロールとしてオーディオブックを使用し、痛みを引き起こす熱刺激を与えた後、脳スキャンで痛みの反応を測定しました。結果として、瞑想は痛みの強度や不快感を大幅に軽減し、脳内で痛みや否定的な感情に関連する神経活動を抑制することが確認されました。一方、プラセボクリームや偽瞑想では、痛みに関連する脳活動に顕著な変化は見られませんでした。この研究は、瞑想による痛み軽減がプラセボ効果とは異なる神経回路を利用していることを示し、慢性痛の治療においてマインドフルネスが有効である可能性を強調しています。

<関連情報>

マインドフルネス瞑想とプラセボは、痛みを軽減するために、異なる多変量神経シグネチャーを調節する Mindfulness meditation and placebo modulate distinct multivariate neural signatures to reduce pain

Gabriel Riegner, Jon Dean, Tor D. Wager, Fadel Zeidan
Biological Psychiatry  Published:August 29, 2024
DOI:https://doi.org/10.1016/j.biopsych.2024.08.023

ABSTRACT

Background
Rather than a passive reflection of nociception, pain is shaped by the interplay between one’s experiences, current cognitive-affective states, and expectations. The placebo-response, a paradoxical yet reliable phenomenon, is postulated to reduce pain by engaging mechanisms shared with “active” therapies. It has been assumed that mindfulness meditation, practiced by sustaining nonjudgmental awareness of arising sensory events, merely reflects mechanisms evoked by placebo. Recently, brain-based multivariate pattern analysis (MVPA) has been validated to successfully disentangle nociceptive-specific, negative-affective, and placebo-based dimensions of the subjective pain experience.

Methods
To determine if mindfulness meditation engages distinct brain mechanisms from placebo and sham-mindfulness to reduce pain, MVPA pain signatures were applied across two randomized clinical trials that employed overlapping psychophysical pain testing procedures (49°C noxious heat; visual analogue pain scales) and distinct fMRI techniques (blood-oxygen-level dependent; perfusion-based). After baseline pain testing, 115 healthy participants were randomized into a four-session mindfulness meditation (n = 37), placebo-cream conditioning (n = 19), sham-mindfulness meditation (n = 20), or book-listening (n = 39) intervention. After each intervention, noxious heat was administered during fMRI and each manipulation.

Results
A double dissociation in the MVPA signatures supporting pain regulation was revealed by mindfulness meditation as compared to placebo-cream. Mindfulness meditation produced significantly greater reductions in pain intensity and pain unpleasantness ratings, nociceptive-specific and negative-affective pain signatures when compared to placebo-cream, sham-mindfulness meditation and controls. Placebo-cream only reduced the placebo-based signature.

Conclusions
Mindfulness meditation and placebo engage distinct neural pain signatures to reduce pain to demonstrate mechanistic granularity between placebo and mindfulness.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました